Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Depreciation & Amortization (CF) (2016 - 2025)

United Therapeutics' Depreciation & Amortization (CF) history spans 17 years, with the latest figure at $22.8 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 15.74% year-over-year to $22.8 million; the TTM value through Dec 2025 reached $85.6 million, up 18.07%, while the annual FY2025 figure was $85.6 million, 18.07% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $22.8 million at United Therapeutics, up from $21.9 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $22.8 million in Q4 2025 and bottomed at $12.4 million in Q2 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $13.3 million (2023), against an average of $15.6 million.
  • The largest annual shift saw Depreciation & Amortization (CF) dropped 3.82% in 2021 before it surged 44.96% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $12.6 million in 2021, then increased by 4.76% to $13.2 million in 2022, then increased by 3.79% to $13.7 million in 2023, then soared by 43.8% to $19.7 million in 2024, then grew by 15.74% to $22.8 million in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Depreciation & Amortization (CF) are $22.8 million (Q4 2025), $21.9 million (Q3 2025), and $21.1 million (Q2 2025).